Market Signal Briefing

Bitcoin held inside a tight range while a liquidation heatmap showed heavy liquidity stacked near $69,000 to $70,000 and another pocket forming around $62,000. On the daily chart, BTC also printed a breakout and retest from a tightening triangle, with $70,000 marked as the next level to clear.

Bitcoin Liquidity Heatmap Shows Key Levels Around $69K and $62KA Bitcoin liquidation heatmap shared by analyst Columbus on X shows BTC trading inside a compressed range while liquidity clusters build above and below the current structure. The four hour BTCUSD chart overlays price action with the MMT heatmap, which highlights areas where large liquidation pools may form.

Bitcoin Liquidation Heatmap Range Structure. Source: Columbus

The chart indicates that liquidity remains concentrated near the $69,000 to $70,000 region. These bands appear as brighter zones on the heatmap, suggesting a higher concentration of potential liquidations if price moves upward into that area. According to the analyst’s commentary, this zone could trigger a short squeeze if traders leaning short are forced to close positions.

Meanwhile, the heatmap also shows a developing liquidity pocket near the $62,000 area. That region sits below the mid range where BTC has been consolidating during recent sessions. If price loses the middle section of the range and momentum shifts lower, the liquidity cluster near $62,000 could act as a potential draw for price.

Recent candles on the chart show Bitcoin moving sideways within the range rather than establishing a directional breakout. Each downward push has met buying activity, while upward attempts have stalled near overhead resistance. As a result, the market continues to compress between the upper liquidity band and the lower pocket.

According to the analyst, the next directional move may emerge once price reaches either liquidity cluster. A move above the upper zone could accelerate momentum through short liquidations, while a drop below the mid range could shift attention toward the lower liquidity pocket.

Bitcoin Daily Chart Shows Breakout and Retest From Triangle CompressionMeanwhile, a daily Bitcoin chart shared by SuperBitcoinBro on X shows BTC breaking above a tightening triangle and then retesting the former resistance line. The chart marks the sequence as “breakout” and “retest,” with the next move framed as a possible continuation if price holds above the reclaimed trendline.

Bitcoin Daily Triangle Breakout and Retest. Source: SuperBitcoinBro

Before the triangle formed, the chart shows a steep selloff that pushed Bitcoin below two labeled reference levels, the November low near $80,524 and the April low near $74,421. After that drop, candles began compressing into a wedge, with lower highs pressing down and higher lows pushing up toward an apex.

The highlighted retest appears after price pushed through the upper boundary of the triangle and then revisited that line. In the same view, the post points to $70,000 as the next level to clear for follow through, while the triangle’s upper trendline now acts as the nearby structure the market is trying to defend.

TLDR: Predict.fun has recorded $1.5 billion in trading volume since launching in December 2025 on BNB Chain. The acquisition brings Probable’s team in-house to accelerate protocol and market architecture development. Probable users get a 2x refund on USDT trading fees and a 1:2 conversion of Probable Points to Predict Points. Predict.fun gains access to Probable’s engaged Asian user base, expanding its geographic reach significantly. Predict.fun, the fastest-growing onchain prediction market on BNB Chain, has finalized its strategic acquisition of Probable. Probable was originally incubated by PancakeSwap and YZi Labs before the deal.

Since its launch in December 2025, Predict.fun has processed $1.5 billion in cumulative trading volume. The platform has also surpassed 120,000 users and logged more than 3.3 million transactions.

This acquisition targets stronger technology, improved market structure, and greater capital efficiency across its operations.

Strengthening Technology and Expanding Market Design The acquisition brings the Probable team directly into Predict.fun’s core development pipeline. This move is expected to accelerate progress across the platform’s existing technology stack.

Work will concentrate on market architecture, execution efficiency, and capital optimization. The deal also positions Predict.fun for deeper integration within the broader BNB DeFi ecosystem.

A key area of development is the expansion of DeFi-derived yield on open positions. Predict.fun plans to evolve this into a multi-source, dynamically routed yield engine.

The engine is designed to materially improve capital efficiency and composability across the platform. Stronger composability also supports more sophisticated market architecture over time.

Dingaling, founder of Predict.fun, shared his remarks on the strategic purpose of the acquisition. “Prediction markets live or die by their liquidity architecture and market design,” he stated.

His comment, posted publicly, reflects the core priority that drove the deal forward. The acquisition, he added, accelerates Predict.fun’s path toward capital-efficient forecasting infrastructure.

Probable’s team also shared its position on joining Predict.fun. “Our vision has always been to push forward market design innovation,” the Probable team stated.

Joining Predict.fun gives the team the distribution, liquidity, and execution layer needed to scale that vision. Both teams see the merger as a foundation for advancing prediction market design.

Transition Process and Rewards for Probable Users Existing Probable.markets users will receive guidance for a streamlined migration to Predict.fun. No immediate changes to user accounts or open positions are expected in the early phase.

Users can expect detailed claiming instructions to be released shortly after the announcement. The transition is designed to be as seamless as possible for current participants.

As part of the deal, Probable users will receive rewards for their early participation. All USDT trading fees paid on Probable as of March 3rd, 2026 will be returned at a 2x value. This refund applies to fees accumulated up to that specific date.

Moreover, Probable Points will convert to Predict Points at a 1:2 ratio. One Probable Point will equal two Predict Points under this arrangement. This conversion rewards those who contributed to the Probable platform from the beginning.

Beyond rewards, the acquisition also extends Predict.fun’s geographic reach. Probable had built a highly engaged user base across key Asian markets prior to the deal.

Absorbing these communities strengthens Predict.fun’s position in Asia’s growing prediction market space. The combined user base adds further depth to trading activity and overall platform liquidity.

Oil benchmarks were up again following a brief reprieve linked to comments from President Donald Trump.

Build-A-Bear CEO Sharon Price John reveals how she transformed the iconic mall-based toy retailer into a multi-platform brand. From a struggling stuffed animal store to a thriving intellectual property company, Price John shares the leadership strategies and creative vision that helped Build-A-Bear's stock soar over the past five years.

Endava plc (DAVA) Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 7:50 PM EST

Company Participants

John Cotterell - Founder, CEO & Director
Alastair Lukies - Chair of Global Advisory Board & Chief Engagement Officer
Mark Thurston - CFO & Director

Conference Call Participants

James Faucette - Morgan Stanley, Research Division

Presentation

James Faucette
Morgan Stanley, Research Division

Thanks for joining us here as we are wrapping up the -- about to wrap up. We still have a keynote after this presentation here at the Morgan Stanley TMT Conference for 2026 on Tuesday, so the second of 4 days. Very thankful to the Endava management team for joining us. Before we get started with them, I'm James Faucette, senior IT services analyst here at Morgan Stanley. And we're very pleased today to have co-CEOs of Endava, John Cotterell and Alastair Lukies. We also have Mark Thurston, CFO.

Before we get started with the team, though, I do have an important disclosure to read. Please see the Morgan Stanley Research Disclosures website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Question-and-Answer Session

James Faucette
Morgan Stanley, Research Division

So I guess with that, I'll just kind of open it up. I'm sure you've gotten the same question multiple times as have we. And it starts with, hey, the recent commentary that you gave coming into the calendar year was actually really encouraging. And I'm wondering if you can walk us through the key factors behind that change. And in particular, what are the things you're looking at that inspires confidence in a stronger fourth quarter pipeline conversion rate?

John Cotterell
Founder, CEO & Director

Sure. I mean we've been, as I've articulated fairly frequently over the last year or so, on a strategic focus

Vistry Group PLC shares tumbled 16% on Wednesday, leading the housebuilding sector lower, as it signalled it will prioritise sales growth and cash generation over margins in the early part of this year.

The company’s full-year results for 2025 were broadly in line with expectations, with adjusted profit before tax rising 2% to £268.8 million despite a 9% drop in completions. The improvement was helped by a shift towards higher-margin sites.

However, investors focused on the outlook. Vistry said sales in the open market (as opposed to via its partnership arm) so far in the new year were up over 40% on last year, "primarily reflecting the success of the targeted pricing initiatives", ie offering pricing incentives to attract buyers.

Analysts at Stifel said the strategy is likely to reduce margins in the near term and could push down consensus profit forecasts by about 5-10%.

The broker said the move should support volumes but warned the immediate effect would be weaker profitability, prompting investors to mark the shares lower.

Vistry also announced that its executive chairman Greg Fitzgerald will retire as chair at the company’s annual meeting in May and will step down from the chief executive role within 12 months.

Barratt Redrow fell 1.6% after it also announced that its boss is retiring after 11 years in the role. 

Bellway fell 1.6%, while Persimmon and Taylor Wimpey also slipped about 1%, and Berkeley was slightly below flat.

Murphy Oil capitalizes on less competitive, high-quality opportunities left by super majors. MUR's strategy prioritizes profitability over smooth growth. The company's production can decline between major discoveries.

Metro Bank Holdings PLC (LSE:MTRO) has reported its highest-ever annual profit, with underlying earnings before tax reaching 98 million pounds in 2025, sending shares up as much as 5% in early trading.

The challenger bank, which came close to collapse in 2023 before a rescue refinancing, has been executing a deliberate shift toward higher-margin business. Net interest income rose 22% year on year, driving a 16% increase in underlying revenue. Its net interest margin, a key measure of lending profitability, exited the year at 3.17%, in line with guidance.

The sharpest growth came in corporate and SME lending, which increased 67% to a record 2 billion pounds. The bank also cut operating costs by 7%, ahead of its own guidance of 4 to 5%, and expanded its store network with new openings in Chester, Salford and Gateshead.

A regulatory reclassification under the MREL regime, which governs how banks hold loss-absorbing capital, has freed up additional capacity for lending growth, something the bank's management flagged as a meaningful operational unlock.

Chief executive Daniel Frumkin said Metro Bank expects to more than double its return on tangible equity during the fourth quarter of 2026 and nearly triple it to above 18% by 2028.

The bank's current RoTE stands at 6.4%. Reaching 18% would place it among the stronger performers on the UK high street.

After the initial burst, the share settled at 116.2p, up 1.8%.

Costco Wholesale (COST +0.50%) has always been a reliable market beater, even in challenging times. But it's experiencing some rare underperformance, and the stock is roughly flat over the past year, even though the business is performing beautifully.

Can Costco stock break out of this cycle? Let's see where it might be in another year from now.

Image source: Getty Images.

Members can't get enough of Costco Costco has a unique membership model that stands out in retail. Although there is competition, including BJ's Wholesale and Walmart's Sam's Club, Costco is the largest of its kind, with nearly 1,000 stores worldwide and $280 billion in trailing 12-month sales.

Essentially, what Costco sells is the membership, which trickles down to the bottom line. Its retail merchandise is marked up with razor-thin margins to just cover associated costs, and membership drives high volume as customers aim to make the most of their annual fees.

There are several metrics that track customer satisfaction. Renewal rates are routinely very high, at around 90% or higher, and more members continue to upgrade to the executive membership, which costs double the $65 annual fee. Executive members are highly engaged, accounting for just under half of total members but 74% of total sales.

Membership upgrades are just one growth avenue for the retail giant. Costco is still opening new stores, both in the U.S. and globally, and it has several other levers to pull, such as its recent $5 annual fee hike and attracting new members. It's embracing digital and e-commerce, which is one of its biggest growth drivers today. Digital signups are now an integral part of its business, and it's drawing younger members to the program.

Sales increased 8.2% year over year in the fiscal 2026 first quarter (ended Nov. 23, 2025), with a 14% increase in fee income (including the fee hike) and a 5.2% increase in membership. These are standard increases for Costco, and high inflation hasn't stopped it.

Costco often does well when the economy is pressured, since customers are more likely to shop at discount stores. I would expect the trend to continue over the next year. This reliability is one of the reasons investors love Costco stock.

Today's Change

(

0.50

%) $

5.00

Current Price

$

1007.77

A hefty price tag In the near term, the market seems to be concerned about how long Costco can keep up sales growth in the face of inflation, and a slight dip in renewal rates, which management attributes to higher digital signups.

But what's driving that is the Costco stock's premium valuation. It's generally more expensive than other retail stocks, since it's so reliable for growth. But it doesn't have a lot of room for error, and if there are any worries, the stock is likely to fall. That seems to be what's happening with Costco stock. Costco stock trades at a price-to-earnings (P/E) ratio of 54, well above the three-year average of 49, which is already expensive. There's a lot built into that price.

If Costco has a flawless year, its stock can rise. However, at this price, there may not be a high upside in the short term. In a year from now, Costco stock may not demonstrate a lot of upward movement unless growth accelerates, and if there are any problems, the stock could fall.

March 4, 2026

CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging and trauma, helping to improve comfort for complex patients and may reduce the need for rescansNext-generation NanoPanel Precise XD detector with AI is built for dose-efficient, high-resolution imaging to support clear visualization and delineation of anatomical structures Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced Rembra [3], its next-generation radiology CT system designed for the realities of acute and high-demand imaging. Rembra will be showcased publicly for the first time at ECR 2026 in Vienna.

Healthcare systems worldwide are under unprecedented pressure. Rising patient volumes, increasing clinical complexity and workforce shortages are pushing frontline, high-acuity and high-demand imaging to its limits. Rembra was engineered from the ground up to meet these challenges, bringing together advanced detector technology, ultra-fast scan and reconstruction speeds and streamlined workflows in a system built for speed, consistency and long-term value.

“Rembra is built for the realities that clinicians face every day,” said Dan Xu, Business Leader for Computed Tomography at Philips. “By combining our most advanced detector technology with AI-powered workflows and industry-leading speed, Rembra represents a significant step forward for high-acuity imaging, delivering speed, access and diagnostic confidence when it matters most.”

Industry-leading speed [1] to support timely clinical decisions
In emergency, trauma and other high-demand settings, delays in image reconstruction can slow diagnosis and impact outcomes. Rembra addresses this challenge with an industry-leading reconstruction speed – up to 106 images per second [1]. This speed is designed to help radiologists and clinicians access images quickly in stroke, trauma and other urgent cases. It may support smoother workflows and timely clinical decisions in busy emergency departments.

Designed for high-demand environments, Rembra can support 270 exams per day [2], helping imaging departments manage growing volumes without compromising speed or confidence.

Optimized patient positioning and access
With the largest-in-class 85 cm bore, Rembra is designed to help facilitate patient access and positioning, and may help improve comfort for trauma, bariatric and interventional cases.

Rembra features a 60 cm standard field of view (sFOV) and an 85 cm extended field of view (eFOV), both the largest in their class of frontline radiology CT systems [4], enabling full anatomical visualization in a single scan. Rembra also features a high-performance patient table with Philips’ best-in-class scan range of up to 2.3 meters and gantry-to-tablespace of 46 cm to support flexible patient positioning.

“In interventional and high acuity settings, precise access and efficient positioning are essential,” said Professor Olivier Rouvière, MD, PhD, Head of Department at Hospices Civils de Lyon (Centre Hospitalier Universitaire de Lyon). “Rembra’s 85 cm bore supports improved access as well as faster and safer positioning of long needles and instruments in complex procedures.”

Clinical performance without compromise
At the heart of Rembra is Philips’ newest NanoPanel Precise XD, a high-density detector designed from the outset to work hand-in-hand with AI. It delivers high dose-efficiency, high-resolution imaging at the source and is designed to support overall image quality and diagnostic confidence.

The detector offers exceptional in-plane spatial resolution of 23 line pairs per cm, enabling sharp detail and visualization of fine anatomical structures down to 0.25 mm. A 2D anti-scatter grid provides strong scatter rejection to help preserve image clarity in challenging patient types, supporting consistently high image quality across patient sizes and clinical scenarios.

AI-designed for productivity, predictability and long-term value
Integrated AI-enabled smart workflows can help automate routine steps and simplify certain operations. These features are intended to support workflow efficiency for consistent results.

Built for operations at high-altitude environments up to 5000m, Rembra is engineered for reliability, durability and long-term performance, supporting a system lifetime of up to 20 years with required maintenance and upgrades. Philips’ industry-first Tube for Life [5] service program further enhances cost predictability by covering tube replacement costs for up to 10 years.

Advancing spectral CT leadership
Also making its European debut at ECR 2026 is Verida, the world’s first detector-based spectral CT powered by AI. Verida integrates AI across the entire imaging chain. First introduced at RSNA 2025, Verida delivers exceptional spectral image quality while helping to accelerate workflows and reduce dose, further reinforcing Philips’ leadership in spectral CT innovation [6,7]. For more information about Verida, please visit the Verida spectral-detector CT scanner page.

[1] Based on publicly available manufacturer specifications for leading radiology CT systems as of March 2026 on reconstruction speed in this class of scanners and bore size.
[2] Based on a sixteen-hour day, with throughput testing with 203 patient scans/ 12 hours for Rembra with typical radiological profiles and protocols.
[3] Pending 510(k) - not available for sale in the USA
[4] The Extended Field of View (EFOV) of 85 cm is intended solely for use in treatment preparation and the planning/simulation of radiation therapy. It cannot be used for diagnostic purposes. The water equivalent material external contour deviation of body system phantom positioned (partially) outside scan FOV with phantom edge adjacent to bore cover shall be within 1mm in terms of mean Hausdorff distance compared to the true external contour.
[5] Tube for Life guarantee availability varies by country. Please contact your local Philips sales representative for details
[6] Andersen MB et al. Impact of spectral body imaging in patients suspected for occult cancer: a prospective study of 503 patients. Eur Radiol2020. doi.org/10.1007/s00330-020-06878-7
[7] Andersen MB et al. Economic impact of spectral body imaging in the diagnosis of patients suspected of occult cancer. Insights into Imaging 2021. doi.org/10.1186/s13244-021-01116-0. Results of customer testimonies are not predictive of results in other cases, where results may vary.

For further information, please contact:
Jayme Maniatis 
Philips Global External Relations  
Tel.: +1 617 804 8368
E-mail: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Philips unveils Rembra CT at ECR 2026 Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-demand imaging

Philips unveils Rembra CT at ECR 2026 Philips unveils Rembra CT at ECR 2026 Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-d... Philips Rembra, a next-generation radiology CT system designed for the realities of acute and high-d...

March 04, 2026 04:39 ET  | Source: Shore Capital Stockbrokers Limited

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)        Name of exempt principal trader:Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:
        Use a separate form for each offeror/offereeCAB Payments Holdings Plc(c)        Name of the party to the offer with which exempt principal trader is connected:CAB Payments Holdings Plc(d)        Date dealing undertaken:03 March 2026(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?No 2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/receivedOrdinaryPurchases11,94986.026p86.026pOrdinarySales11,94986p86p (b)        Derivatives transactions (other than option)

Class of relevant securityProduct description
e.g. CFDNature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit      (c)        Options transactions in respect of existing securities

(i)        Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType
e.g. American, European etc.Expiry dateOption money paid/ received per unit         (ii)        Exercising

Class of relevant securityProduct description
e.g. call optionNumber of securitiesExercise price per unit     (d)        Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing
e.g. subscription, conversionDetailsPrice per unit (if applicable)     The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.        OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
If there are no such agreements, arrangements or understandings, state “none”None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:
(i)        the voting rights of any relevant securities under any option; or
(ii)        the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state “none”None

Date of disclosure:04 March 2026Contact name:Clare Gamble-DaleTelephone number:0207 601 6132 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

DFI Retail Group Holdings Limited (DFIHY) Q4 2025 Earnings Call March 3, 2026 8:30 PM EST

Company Participants

Karen Chan - Strategy & Investor Relations Director
Scott Price - Group CEO & Director
Tom Cornelis Van der Lee - Group CFO & Director

Conference Call Participants

Ming Jie Kiang - CLSA Limited, Research Division

Presentation

Karen Chan
Strategy & Investor Relations Director

Good morning, everyone. Thank you for attending the DFI Retail Group 2025 Full Year Results Presentation. I'm Karen Chan, Strategy and Investor Relations Director. Joining us today is Scott Price, Group Chief Executive; and Tom Van der Lee, Group Chief Financial Officer, who will be providing remarks on our full year results, followed by a Q&A session. Today's presentation is being webcast in its entirety. In addition, the full text of our results announcement and slide presentation are uploaded on to our IR website.

And before we start, I would like to remind you of the following regarding information to be provided during the presentation. The information about to be presented is for information purposes only and is not intended to be investment advice for any person. There's no intention to imply for any dealings in any securities. There may be forward-looking statements mentioned in the presentation materials, which include statements regarding our intent, belief, expectation with respect to DFI Retail Group businesses operations, market conditions, et cetera. You're expressly advised not to rely on these forward-looking statements as they are subjective views, which are subject to risks and uncertainties.

And with that, I'll pass it over to Scott. Scott, please.

Scott Price
Group CEO & Director

Good morning, everyone. Thank you, Karen. A pleasure to be here talking about our full year of 2025 results and also sharing with you some of the insights that we gleaned from the second half of

U.S. equity futures pointed to another day of falls. Stocks in Japan and Korea fell dramatically, but selling in European shares eased at market open.

2.35K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MPLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Successful investing involves patiently holding shares in a growing business -- that's all there is to it. But sometimes, market pullbacks create rare opportunities to buy shares in a competitively positioned business at a valuation that may underestimate its future growth, setting up even better returns for patient investors.

MercadoLibre (MELI 3.59%), Coupang (CPNG 3.15%), and Airbnb (ABNB 0.17%) are three such stocks that are currently underappreciated by the market. Here's why investors may want to consider adding these top stocks to their portfolio.

Image source: Getty Images.

1. MercadoLibre Shares of MercadoLibre are up more than 1,500% over the last 10 years, but the stock's pullback has brought its valuation down to the lowest level in years. This is a consistent high-growth business that is dominating Latin America's e-commerce and fintech markets, presenting a compelling investment opportunity.

Its competitive moat is based on the combination of valuable services it offers to customers: payments, credit, and membership benefits that drive higher loyalty and shopping frequency. These services, along with its growing advertising business, boost the company's profits, which it can reinvest in improvements to the customer experience, creating a powerful flywheel effect.

Today's Change

(

-3.59

%) $

-63.86

Current Price

$

1713.14

Revenue rose 45% year over year in the fourth quarter. Unit shipping costs fell in Brazil, one of its top markets, by 11% year over year, driven by automation.

The company's profit margin dipped over the past year, which may explain the stock's pullback. Still, MercadoLibre will continue to see its margins trend higher over the long term as it expands its high-margin fintech services and invests in automation that lowers costs.

This opportunity is why the stock might be undervalued. The shares are trading at a price-to-sales multiple (P/S) of 3.1, the lowest in more than 10 years.

2. Coupang Coupang is the leader in South Korea's e-commerce market, and it's starting to show the potential to profitably expand into other countries, such as Taiwan. The stock has fallen 21% year to date and now trades at a sales multiple of about 1. This values the company at just one year of revenue but leaves attractive upside over the next several years as it grows and improves margins.

Coupang has invested billions over several years in its fulfillment network and logistics operations. It differentiates itself from a global leader like Amazon by specifically designing its service to efficiently deliver packages in densely populated cities, including tall apartment buildings. This allows the company to deliver most orders in Korea through its Rocket Delivery service within hours.

Today's Change

(

-3.15

%) $

-0.63

Current Price

$

19.20

It reported triple-digit revenue growth in Taiwan last quarter, demonstrating that its business model can be successfully adapted to other highly populated areas outside its home market.

The stock is down after fourth-quarter revenue growth decelerated to just 11% year over year -- significantly down from the previous quarter's 18%. This was caused by a data breach that stalled its momentum, as customers had to reset their passwords. But with management noting a recovery at the start of the year, this pullback appears to be a buying opportunity.

3. Airbnb Airbnb started in its founders' San Francisco apartment in 2007 and has grown into a global platform serving over 5 million hosts and more than 2.5 million guests. The stock has been range-bound the past several years, but the company has continued to grow, and the stock is now offering solid value, trading at just 18 times free cash flow.

The company is serving a growing industry. A 2025 report from the World Travel & Tourism Council showed that travel spending was expected to contribute about 10% to the global economy last year. It's a multitrillion-dollar market with ample long-term potential for Airbnb.

Today's Change

(

-0.17

%) $

-0.22

Current Price

$

133.04

Airbnb benefits from a capital-light model, generating revenue from fees, and it doesn't have to spend money on facility maintenance, like large hotel chains do. This allows management to convert its $12.3 billion in annual revenue into $4.6 billion in free cash flow, a high free-cash-flow margin of 37%.

Investments in artificial intelligence (AI) could drive margins higher. The company created a custom AI agent, which is currently handling about a third of customer support issues. And it draws on a huge pool of data, including 200 million verified identities and 500 million reviews, which competitors can't replicate.

Airbnb has a strong brand, unique destinations for guests, and solid prospects in a growing industry. Its modest valuation should set up favorable prospects for investors.

With over 450,000 sqm and 4,000 employees, GXO’s Polish operations
are its largest in Central Europe

GXO celebrated the opening of its new Central Europe headquarters in Warsaw honoring dozens of colleagues who have been with the company for more than 18 years

Poland is currently the fifth-largest logistics and warehouse market in Europe and the third largest in terms of demand, confirming its role as a key logistics hub in the region

WARSAW, Poland, March 04, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today marked 20 years of transforming the logistics landscape in Poland, the fifth-largest logistics market in Europe. Over two decades, GXO has become synonymous with innovation and operational excellence in the region, leveraging advanced automation and deep sector expertise to deliver high-performing solutions for leading brands in ecommerce, omnichannel retail, fashion, FMCG and DIY.

“Celebrating 20 years of growth in Poland is a testament to our long-standing partnerships with our customers in all industries, led by our focus on innovation, automation and continuous improvement,” said Jean Luc Bessade, Managing Director, Poland, Czech Republic and Romania, GXO. “At GXO, we’re always looking ahead, to empower our people, elevate our customers and build innovative supply chains, as we continually raise the bar to deliver greater value and impact for our customers.”

Since commencing operations in Poland, GXO has pioneered advanced logistics solutions, including state-of-the-art warehousing, order fulfilment, returns management and factory logistics. The company’s operations are powered by adaptive technologies such as AMR robots, ProGlove and Cognex scanners, automated packaging, and integrated WMS software, ensuring seamless processes from production lines to delivery. GXO’s commitment to innovation is reflected in its ISO and BREEAM certifications and its ability to serve a wide range of sectors.

GXO’s long-standing partnerships underscore its reputation for operational excellence and customer trust. The company’s inclusion in the 2025 Forbes Diamonds list as one of Poland’s most dynamic companies is a testament to its growth and impact.

With over 4,000 employees in Poland and a team representing more than 30 nationalities, GXO fosters a diverse and inclusive workplace. The company’s culture of respect, safety, and career development is evidenced by its strong engagement rate and the long tenure of many colleagues – some with over 18 years of service. GXO’s “Career Academy” program, conducted in partnership with Koźmiński University, the University of Economics in Katowice and the University of Łódź, nurtures the next generation of logistics experts by offering classes, internships and apprenticeships.

GXO’s influence extends beyond logistics. Through ESG initiatives, charity runs, football tournaments and environmental campaigns, the company actively supports the communities where it operates. Its ongoing collaboration with logistics associations like Polish Supply Management Leaders and recognition by the Responsible Business Forum highlight GXO’s dedication to sustainable growth and industry development.

About GXO
GXO Logistics, Inc. (NYSE: GXO) is the world’s largest pure-play contract logistics provider and is positioned to capitalize on the rapid growth of ecommerce, automation and outsourcing. GXO has over 150,000 team members across more than 1,000 facilities, totalling more than 200 million square feet. The company serves the world’s leading blue-chip companies to solve complex logistics challenges with technologically advanced supply chain and ecommerce solutions, at scale and with speed. GXO corporate headquarters is in Greenwich, Connecticut. Visit GXO.com for more information and connect with GXO on LinkedIn, X, Facebook, Instagram and YouTube.

Media contact

Anne Lafourcade
+33 (0)6 75 22 52 90

[email protected]

IP Group PLC (LSE:IPO), the London-listed science and technology investor, said portfolio company Oxa Autonomy has raised $103 million in the first close of a Series D funding round, backed by the UK's National Wealth Fund and NVentures, the venture capital arm of chip designer Nvidia.

IP Group invested £7.5 million from its own balance sheet and a further £19 million through funds it manages on behalf of Australian pension fund Hostplus, giving it a combined beneficial holding of 20.3% in Oxa.

The National Wealth Fund committed an initial $50 million to the round, with bp Ventures, the investment arm of the oil major, among the other participants.

Oxa, a self-driving vehicle software company, will use the proceeds to accelerate commercialisation of what it calls Industrial Mobility Automation, the use of autonomous driving technology to handle repetitive driving tasks in environments such as ports, airports and logistics facilities.

Greg Smith, chief executive of IP Group, said the calibre of investors in the round "underlines the growing conviction behind Oxa's leadership" in the sector, adding that the company's "universal AI driver" approach positioned it to scale across industrial vehicles and environments as adoption accelerates.

Volvo reveals their Volvo EX30 fully-electric small SUV vehicle during an event in Milan, Italy June 7, 2023. REUTERS/Claudia Greco/File Photo Purchase Licensing Rights, opens new tab

CompaniesSTOCKHOLM, March 4 (Reuters) - Sweden-based Volvo Cars (VOLCARb.ST), opens new tab said ‌on Wednesday it sold 156,965 cars in the three months through ​February, down 10% from ​the same period a year ⁠earlier, but sales of fully ​electric cars increased 18%.

"Our sales ​for the period were impacted by the continued tough market conditions, impacted ​by tariffs and unfavourable regulatory ​developments especially in the U.S.. The prolonged ‌new ⁠year holiday period in China further affected our performance," it said in a statement.

The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.

"However, ​we are ​pleased ⁠to see steady growth in the sales of ​our fully electric cars."

Shares ​in ⁠the company, which is due to publish its first-quarter earnings ⁠report ​on April 29, ​were up 1% in early trade.

Reporting by ​Anna Ringstrom, editing by Louise Rasmussen

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Nasdaq futures lead early losses; Asian stocks sink

- Earnings Call Scheduled for 8:00 AM ET on March 24, 2026 - March 04, 2026 03:30 ET  | Source: Hesai Group

SHANGHAI, China, March 04, 2026 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI; HKEX: 2525), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it will report its fourth quarter and full year 2025 unaudited financial results on Tuesday, March 24, 2026, before the U.S. market opens.

The Company’s management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 24, 2026 (8:00 PM Beijing/Hong Kong Time on March 24, 2026).

For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the scheduled call start time. Upon registration, each participant will receive dial-in details to join the conference call.

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at https://investor.hesaitech.com.

A replay of the conference call will be accessible approximately an hour after the conclusion of the call until March 31, 2026, by dialing the following telephone numbers:

United States:+1-855-883-1031International:+61-7-3107-6325Hong Kong, China:800-930-639China Mainland:400-120-9216Replay PIN:10052900   About Hesai

Hesai Technology (Nasdaq: HSAI; HKEX: 2525) is a global leader in lidar solutions. The Company’s lidar products enable a broad spectrum of applications including passenger and commercial vehicles ("ADAS"), as well as autonomous driving vehicles and robotics and other non-automotive applications such as last-mile delivery robots and AGVs ("Robotics"). Hesai seamlessly integrates its in-house manufacturing process with lidar R&D and design, enabling rapid product iteration while ensuring high performance, high quality and affordability. The Company’s commercially validated solutions are backed by superior R&D capabilities across optics, mechanics, and electronics. Hesai has established offices in Shanghai, Palo Alto and Stuttgart, with customers spanning more than 40 countries.

For more information, please visit: https://investor.hesaitech.com.

For investor and media inquiries, please contact:

Hesai Group
Yuanting “YT” Shi, Head of Capital Markets
Email: [email protected]

Christensen Advisory
Tel: +86-10-5900-1548
Email: [email protected]

Source: Hesai Group

-

SINGAPORE--(BUSINESS WIRE)--On 3 March 2026, certain primary insiders of Hafnia Limited ("Hafnia", the "Company", OSE ticker code: "HAFNI", NYSE ticker code: "HAFN") have, in total, exercised 725,019 vested options granted under the Company's ordinary long-term investment plan in accordance with its vesting schedule at an exercise price of NOK 44.11 per option, and sold a corresponding number of shares in Hafnia in the market in a joint sale through a broker.

The exercised options have been settled by the Company by transfer of treasury shares. Following the transfer, the Company holds 12,843,201 treasury shares.

For more information see the attached mandatory notifications of trade.

About Hafnia Limited:

Hafnia is one of the world's leading tanker owners, transporting oil, oil products and chemicals for major national and international oil companies, chemical companies, as well as trading and utility companies.

As owners and operators of around 200 vessels, we offer a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk. Hafnia has offices in Singapore, Copenhagen, Houston, and Dubai and currently employs over 4000 employees onshore and at sea.

Hafnia is part of the BW Group, an international shipping group involved in oil and gas transportation, floating gas infrastructure, environmental technologies, and deep-water production for over 80 years.

This information is subject to disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

More News From Hafnia Limited

Back to Newsroom

2.07K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of BN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

1.52K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of BOLSY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

4.85K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ®Phase 3 trial of daridorexant in South Korea met both primary and secondary efficacy endpoints of subjective total sleep time (sTST), subjective latency to sleep onset (sLSO) and subjective wake after sleep onset (sWASO) Tokyo, Japan and Cambridge, UK, 4 March 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has submitted a marketing authorisation application (MAA) to the Ministry of Food and Drug Safety (MFDS) in South Korea for daridorexant, a dual orexin receptor antagonist, for the treatment of adult patients with insomnia. This submission follows positive data from the Phase 3 trial of daridorexant in South Korea which met both primary and secondary efficacy endpoints (Link).

Insomnia, characterized by difficulties in sleep onset and/or sleep maintenance, impacts both physical and mental health. The condition is highly prevalent in South Korea, affecting 15-25% of the adult population, or approximately 6.5-11 million people1,2.

Mr. MinBok Lee, President and Representative Director of Nxera Pharma Korea, commented: “This submission represents a key milestone in our efforts to expand access to daridorexant in South Korea. With the medicine already approved and marketed in Japan, we look forward to sharing further progress as it advances through the regulatory review process in South Korea towards anticipated approval in 2027.”

Daridorexant is approved and marketed in Japan as QUVIVIQ® under a commercialization agreement between Nxera and Shionogi. QUVIVIQ®, discovered by Idorsia Pharmaceuticals, is marketed by Idorsia in the US, Canada, and multiple European countries, and marketed by Simcere in China and Hong Kong.

–END–

Notes to Editors

About Insomnia Disorder
Insomnia disorder is defined as difficulty initiating or maintaining sleep, causing clinically significant distress or impairment in important areas of daytime functioning. As defined this impact on sleep quantity or quality should be present for at least three nights per week, lasts for at least three months, and occurs despite an adequate opportunity to sleep.

Insomnia is a condition of overactive wake signaling and studies have shown that areas of the brain associated with wakefulness remain more active during sleep in patients with insomnia. The disorder is quite different from a brief period of poor sleep, and it can take its toll on both physical and mental health. It is a persistent condition with a negative impact on daytime functioning. Research has shown that poor quality sleep can affect many aspects of daily life, including the ability to concentrate, mood, and energy levels.

The goal of treatments for insomnia is to improve sleep quality and quantity, as well as daytime functioning, while avoiding adverse events and next-morning residual effects. Current recommended treatment of insomnia includes sleep hygiene therapy, cognitive behavioral therapy, and pharmacotherapy.

According to multiple epidemiological studies, insomnia affects around 15% to 25% of the adult population in South Korea, or approximately 6.5-11 million people1,2. The condition is notably more prevalent among women and older adults. Recent data from Korea’s Health Insurance Review and Assessment Service (HIRA) revealed that the number of chronic insomnia patients treated has increased by 21% from 597,529 in 2018 to 722,440 in 2022. Of these patients, 50% are aged 60 or above, and 61% are women.

1Epidemiology of Insomnia in Korean Adults: Prevalence and Associated Factors (Print ISSN 1738-6586 / On-line ISSN 2005-5013)
2The Prevalence and Incidence of Insomnia in Korea during 2005 to 2013 / Print ISSN 1738-3684 / On-line ISSN 1976-3026)

About the Orexin system
Wake and sleep signaling is regulated by intricate neural circuitry in the brain. One key component of this process is the orexin system, which helps promote wakefulness. There are two forms of orexin neuropeptides – small protein-like molecules used by nerve cells (neurons) to communicate with each other in the brain – orexin A and orexin B. Orexin promotes wakefulness through its receptors OX1R and OX2R. Together, these neuropeptides and receptors make up the orexin system. The orexin system stimulates targeted neurons in the wake system – leading to the release of several chemicals (serotonin, histamine, acetylcholine, norepinephrine) – to promote wakefulness. Orexin regulates wake signaling, which might be overactive at night, preventing people with insomnia from falling asleep or staying asleep. Daridorexant is a dual orexin receptor antagonist (DORA) that equipotently antagonizes orexin receptors 1 and 2, consequently decreasing overactive wake signals throughout the entire night.

About the Phase 3 study
The Phase 3 trial was a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial designed to evaluate the efficacy and safety of daridorexant in adult and elderly patients with insomnia. Patients were randomized to receive daridorexant 50 mg or placebo once daily for 28 days.

The study met both its primary and secondary efficacy endpoints. At Day 28, daridorexant significantly improved the primary efficacy endpoint, the change from baseline in subjective total sleep time (sTST), compared with placebo (p<0.0001 for the 50 mg dose). Daridorexant also significantly improved the secondary efficacy endpoints, the change from baseline at Day 28 in subjective latency to sleep onset (sLSO) and subjective wake after sleep onset(sWASO), compared with placebo (both p<0.0001 for the 50 mg dose). The incidence of adverse events was comparable between the daridorexant and placebo treatment groups. The rate of treatment-emergent adverse events (TEAEs) during the double-blind treatment period was comparable between placebo and daridorexant, reported in 13.41% of patients treated with daridorexant 50 mg and 14.81% for placebo.

About Nxera Pharma
Nxera Pharma is a technology powered biopharma company in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. The Company has built an agile, new-generation commercial business in Japan to develop and commercialize innovative medicines, including several launched products, to address this high-value, large and growing market and those in the broader APAC region. In addition, the Company is advancing an extensive pipeline internally and in partnership with leading pharma and biotech companies powered by its unique NxWave™ GPCR structure-based drug discovery platform. Nxera Pharma operates at key locations in Tokyo and Osaka (Japan), London and Cambridge (UK), Basel (Switzerland) and Seoul (South Korea) and is listed on the Tokyo Stock Exchange (ticker: 4565).

For more information, please visit www.nxera.life
LinkedIn: @NxeraPharma | X: @NxeraPharma | YouTube: @NxeraPharma

QUVIVIQ® is trademark of Idorsia Ltd.

Enquiries

Media and Investor Relations
Shinya Tsuzuki, VP, Head of Investor Relations
Maya Bennison, Communications Manager
+81 (0)3 5962 5718 | +44 (0)1223 949390 |[email protected]

MEDiSTRAVA (for International Media)
Mark Swallow, Frazer Hall, Erica Hollingsworth
+44 (0)203 928 6900 | [email protected]

Forward-looking statements
This press release contains forward-looking statements, including statements about the discovery, development, and commercialization of products. Various risks may cause Nxera Pharma Group’s actual results to differ materially from those expressed or implied by the forward looking statements, including: adverse results in clinical development programs; failure to obtain patent protection for inventions; commercial limitations imposed by patents owned or controlled by third parties; dependence upon strategic alliance partners to develop and commercialize products and services; difficulties or delays in obtaining regulatory approvals to market products and services resulting from development efforts; the requirement for substantial funding to conduct research and development and to expand commercialization activities; and product initiatives by competitors. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statements. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.